Trial intelligence / Profile preview

MBL-HCV1 in HCV-infected patients undergoing liver transplantation

NCT01121185Phase 2Terminated

Sponsor
MassBiologics
Start
Jun 2010
Primary completion
Jun 2011
Countries
1
01

Overview

A Phase 2 trial of MBL-HCV1 in hepatitis C virus infection, sponsored by MassBiologics. Started Jun 2010; status: terminated.

02

Drugs

MBL-HCV1
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NCT01121185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01121185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call